PERSPECTA

News from every angle

Back to headlines

Syngenis Labs Secures R&D Refund and Funding for Biotech Expansion

Biotech firm Syngenis Labs has received a $363,000 R&D refund and completed a $4 million pre-float raise to develop its integrated AI, RNA, DNA, and manufacturing platform in Perth.

24 Aug, 23:05 — 24 Aug, 23:05
PostShare